Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation

NCT01483274 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Adult patient population barriers.

Conditions

Acute Myelogenous Leukemia

Interventions

BIOLOGICAL: Vaccine

Sponsor

University of Louisville